Compare MGTX & PZZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | PZZA |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2018 | 1995 |
| Metric | MGTX | PZZA |
|---|---|---|
| Price | $11.77 | $31.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | $24.57 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 817.3K | 783.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 5.25% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $81,391,000.00 | ★ $2,068,421,000.00 |
| Revenue This Year | $141.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $144.24 |
| Revenue Growth | ★ 144.57 | 14.07 |
| 52 Week Low | $6.62 | $29.89 |
| 52 Week High | $15.35 | $55.74 |
| Indicator | MGTX | PZZA |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 41.74 |
| Support Level | $8.84 | $30.93 |
| Resistance Level | $15.35 | $35.36 |
| Average True Range (ATR) | 0.67 | 1.35 |
| MACD | -0.20 | -0.32 |
| Stochastic Oscillator | 20.85 | 35.02 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.